July 26, 2016

Polpharma Group acquired Bioceros

Bioceros has a high-yield cell line development platform as well as comprehensive process development and analytical capabilities. It will be integrated with Polpharma Group’s Biologics Unit to support the development of biosimilars and other biotechnological drugs for global markets. “We are very happy to add an industry-leading cell line technology platform, great process development capabilities […]

Read More


For media inquiries, please contact:

Kamila Oliwa-Stasiak,

Senior Communication Specialist.